loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

Approved Drug Products containing 203270 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 AUROBINDO PHARMA (3)

filter

01 CAPSULE, DELAYED REL PELLETS;ORAL (3)

filter

01 RX (3)

filter

01 OMEPRAZOLE (3)

filter

01 No (3)

URL Supplier Web Content
CAPSULE, DELAYED R...
40MG
2015-08-19
203270
OMEPRAZOLE
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE, DELAYED R...
10MG
2015-08-19
203270
OMEPRAZOLE
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE, DELAYED R...
20MG
2015-08-19
203270
OMEPRAZOLE
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 203270

Looking for FDA Orange Book APPLICATION 203270 3

19

Aurobindo Pharma Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is OMEPRAZOLE, with a corresponding application number 203270.

Regulatory Information RX

With a dosage strength 40MG

Dosage Form Route CAPSULE, DELAYED REL PELLETS; ORAL

Reference Listed Drug No

Approved since 2015-08-19

Therapeutic Equivalence (TE) Code AB

18

Aurobindo Pharma Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is OMEPRAZOLE, with a corresponding application number 203270.

Regulatory Information RX

With a dosage strength 10MG

Dosage Form Route CAPSULE, DELAYED REL PELLETS; ORAL

Reference Listed Drug No

Approved since 2015-08-19

Therapeutic Equivalence (TE) Code AB

17

Aurobindo Pharma Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is OMEPRAZOLE, with a corresponding application number 203270.

Regulatory Information RX

With a dosage strength 20MG

Dosage Form Route CAPSULE, DELAYED REL PELLETS; ORAL

Reference Listed Drug No

Approved since 2015-08-19

Therapeutic Equivalence (TE) Code AB

Post Enquiry
POST ENQUIRY